Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00045968
Status:
UNKNOWN
Last Update Posted:
2022-05-18
First Post:
2002-09-17
Brief Title:
Study of a Drug DCVax-L to Treat Newly Diagnosed GBM Brain Cancer
Sponsor:
Northwest Biotherapeutics
Organization:
Northwest Biotherapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Brain Tumor |
| Glioblastoma Multiforme |
| Glioblastoma |
| GBM |
| Grade IV Astrocytoma |
| Glioma |
| Brain Cancer |
Keywords:
| Name | View |
|---|---|
| Grade IV brain cancer | View |
| oncology | View |
| neurology | View |
| glioma | View |
| brain tumor | View |
| brain cancer | View |
| glioblastoma multiforme | View |
| glioblastoma | View |
| newly diagnosed glioblastoma | View |
| immunotherapy | View |
| dendritic cells | View |
| immune therapy | View |
| GBM | View |
| Brain cancer primary | View |
| tumor vaccine | View |
| grade IV astrocytoma | View |
| DCVax | View |